Barriers to clinical trial participation by older women with breast cancer.
about
Incentives and disincentives to participation by clinicians in randomised controlled trialsHealth status in older hospitalized patients with cancer or non-neoplastic chronic diseasesUnderstanding the attitudes of the elderly towards enrolment into cancer clinical trials.Geriatric oncology: problems with under-treatment within this populationBenefits of Minimal Access Surgery in Elderly Patients with Pelvic CancerTreating Elderly Patients With Hormone Receptor-Positive Advanced Breast CancerRole of frailty and sarcopenia in predicting outcomes among patients undergoing gastrointestinal surgeryTreatment of Elderly Patients with Squamous Cell Carcinoma of the Head and NeckDoes random treatment assignment cause harm to research participants?The National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: summary and recommendationsThe Treatment of Primary Breast Cancer in Older Women With Adjuvant Therapy: A Retrospective Analysis of Data From Over 3000 Patients From the PATH Biobank, With Two-Year Follow-upSentinel node skills verification and surgeon performance: data from a multicenter clinical trial for early-stage breast cancer.Comparative analysis of the efficacy and safety of chemotherapy with oxaliplatin plus fluorouracil/leucovorin between elderly patients over 65 years and younger patients with advanced gastric cancer.Participation of older newly-diagnosed cancer patients in an observational prospective pilot study: an example of recruitment and retentionAmongst eligible patients, age and comorbidity do not predict for dose-limiting toxicity from phase I chemotherapy.Delivering High-Quality Cancer Care: The Critical Role of Quality Measurement.Breast cancer and aging: results of the U13 conference breast cancer panelPatients and Methods of the PATH Biobank - A Resource for Breast Cancer ResearchThe Role of Clinical Trial Participation in Cancer Research: Barriers, Evidence, and Strategies.Cancer and ageism.The value of observational cohort studies for cancer drugs.Geriatric oncology: an overview of progresses and challenges.Breast cancer adjuvant chemotherapy decisions in older women: the role of patient preference and interactions with physicians.Designing therapeutic clinical trials for older and frail adults with cancer: U13 conference recommendationsBreast Cancer in Special Situations.Breast conserving surgery versus mastectomy: the influence of comorbidities on choice of surgical operation in the Department of Defense health care systemRecruitment of African Americans to National Oncology Clinical Trials through a clinical trial shared resourceExclusion of older patients from ongoing clinical trials for hematological malignancies: an evaluation of the National Institutes of Health Clinical Trial Registry.Direct-to-patient disclosure of results of mismatch repair screening for Lynch syndrome via electronic personal health record: a feasibility study.Adjuvant chemotherapy in older women with early-stage breast cancer.Barriers to recruitment of rural patients in cancer clinical trials.Phase I Clinical Trials in Patients ≥80External validity of a trial comprised of elderly patients with hormone receptor-positive breast cancer.Assessment of perceived cost to the patient and other barriers to clinical trial participation.Attitudinal barriers to participation in oncology clinical trials: factor analysis and correlates of barriersFactors influencing participation in a randomized controlled resistance exercise intervention study in breast cancer patients during radiotherapy.Impact of Adjuvant Chemotherapy on Breast Cancer Survival: A Real-World PopulationTreatment options for early breast cancer in elderly women.Biological, clinical, and psychosocial correlates at the interface of cancer and aging research.Oncological and surgical outcome of total laryngectomy in combination with neck dissection in the elderly.
P2860
Q24245558-7C20EF8B-01B9-49DA-A936-2EBC462EB7CFQ24812070-D1BC1A5C-9957-49DE-8DB0-8D28AF04DF0EQ25257182-5B9E674E-9B77-491B-9ADF-5C99FED23285Q26771401-8AA9000D-FCE5-4E33-9724-583ADDCB82D1Q26771710-A0319688-BAEC-4CEF-B94E-4E0A9233E272Q26785496-64915580-1A02-4F74-A7A3-1C78ECDCA030Q26827248-474B6E34-4351-48E9-956F-C89CEB90C68DQ28076894-68A6F545-A0D6-4D33-A559-9139D4681B18Q28768704-D386F6D0-5C68-4ECC-9BC4-E371CFF241B4Q30557206-99217037-B9A0-49F8-BD94-97EE2E3F7D27Q30993896-B08E39B1-576A-48BE-A49D-D3B68AB35263Q33224183-5B2C93A9-4522-438B-99B9-7090C5AC391AQ33399154-695B2982-A13E-4A69-82C6-1C5935C728C2Q33491875-D7DD7601-6C8A-47F7-9C63-217F70B21C27Q33601715-118B9F53-AD62-4E4E-B308-A58E0C111524Q33613935-C002FB84-D1CB-431E-8A92-9412B4553F46Q33829433-C9F2A110-BF65-4E2D-BB9F-80AD4AF47BF2Q33832256-82752B1C-E6F6-4D42-8D68-8A327689956DQ33865329-9CF449A7-154C-41C7-9962-5C4363E40570Q33893922-83412234-C2E2-45C9-A1C0-E33A703EEDC9Q33973945-E4B658D7-A0C7-4ED4-BF92-DCA62F775C8CQ33979972-D22414EA-66E6-4AD8-9839-6F578C7A0595Q33990818-84D11030-E7E1-45B9-A444-3CD8D223BEC7Q34031134-E4680D96-B87B-4503-8239-64A5F1FB51D4Q34096321-590AE0BA-8E2E-457A-8F34-2D6891C3074FQ34107526-BF52473D-0EFB-447C-BF6F-152B7658AA50Q34242249-7EA4D6A6-507B-42F1-ADDD-345B0A40AE2AQ34359352-1F9D37D5-7BC6-440D-8CFE-5E121FE2E18AQ34437807-6C998659-8EEC-4EB2-9B64-898D1E922D22Q34858284-F406DE3D-E098-4220-8E29-4749933625E0Q34974911-46FC0EDC-EC6C-4973-81ED-F86D473E0732Q34990971-9A81AB71-2720-447A-BB72-6B2D7ECD69E8Q35125211-0C2CF12B-2E73-4932-AEC9-20E25E4ECD95Q35205695-E9F1B7BF-1B42-4CB6-9171-CA96ADB35642Q35563968-5A5B1157-6379-4022-8024-AB0326AA51D2Q35606109-B08DD468-A513-4849-AE30-4F399F9C1A44Q35716564-731F787E-44EC-481A-85B5-D02E86D80C1AQ35728668-1119B959-50B1-42B9-A69A-6F39EC30FDE3Q35894352-49F0D3C2-1D41-4D8C-9BD6-D6C799A1873BQ35955479-1148BCA5-73F2-4A4D-985E-64B2ED688DB3
P2860
Barriers to clinical trial participation by older women with breast cancer.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Barriers to clinical trial participation by older women with breast cancer.
@en
Barriers to clinical trial participation by older women with breast cancer.
@nl
type
label
Barriers to clinical trial participation by older women with breast cancer.
@en
Barriers to clinical trial participation by older women with breast cancer.
@nl
prefLabel
Barriers to clinical trial participation by older women with breast cancer.
@en
Barriers to clinical trial participation by older women with breast cancer.
@nl
P2093
P356
P1476
Barriers to clinical trial participation by older women with breast cancer
@en
P2093
Alice B Kornblith
Bercedis L Peterson
Ellis Levine
Gini Fleming
Harvey J Cohen
Hyman B Muss
Judith Wheeler
M Margaret Kemeny
P304
P356
10.1200/JCO.2003.09.124
P407
P577
2003-06-01T00:00:00Z